Abstract:Microbial species that dwell human bodies have profound effects on overall health and multiple pathological conditions. The tumor microenvironment (TME) is characterized by disordered vasculature, hypoxia, excessive nutrition and immunosuppression. Thus, it is a favorable niche for microbial survival and growth. Multiple lines of evidence support the existence of microorganisms within diverse types of cancers. Like gut microbiota, intratumoral microbes have been tightly associated with cancer pathogenesis. Intratumoral microbiota can affect cancer development through various mechanisms, including induction of host genetic mutation, remodeling of the immune landscape and regulation of cancer metabolism and oncogenic pathways. Tumor-associated microbes modulate the efficacy of anticancer therapies, suggesting their potential utility as novel targets for future intervention. In addition, a growing body of evidence has manifested the diagnostic, prognostic, and therapeutic potential of intratumoral microorganisms in cancer. Nevertheless, our knowledge of the diversity and biological function of intratumoral microbiota is still incomplete. A deeper appreciation of tumor microbiome will be crucial to delineate the key pathological mechanisms underlying cancer progression and hasten the development of personalized treatment approaches. Herein, we summarize the most recent progress of the research into the emerging roles of intratumoral microbiota in cancer and towards clarifying the sophisticated mechanisms involved. Moreover, we discuss the effect of intratumoral microbiota on cancer treatment response and highlight its potential clinical implications in cancer.

Multifaceted metabolic role of infections in the tumor microenvironment

The Impact of Gut Microbiota-Derived Metabolites on the Tumor Immune Microenvironment

Metabolic Interplay in the Tumor Microenvironment: Implications for Immune Function and Anticancer Response

Microbiota Manipulation as an Emerging Concept in Cancer Therapy

Intracellular bacteria in cancer—prospects and debates

Effects of intratumoral microbiota on tumorigenesis, anti-tumor immunity, and microbe-based cancer therapy

The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor?

Microbial metabolites affect tumor progression, immunity and therapy prediction by reshaping the tumor microenvironment (Review)

The crosstalk of intratumor bacteria and the tumor

Intratumoral Microbiota as a Target for Advanced Cancer Therapeutics

Intratumor microbiota in cancer pathogenesis and immunity: from mechanisms of action to therapeutic opportunities

Fungal Influence on Immune Cells and Inflammatory Responses in the Tumor Microenvironment (Review)

The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors

Tumor-targeting bacteria as immune stimulants – the future of cancer immunotherapy?

Microenvironmental Metabolism Regulates Antitumor Immunity

Harnessing Bacterial Agents to Modulate the Tumor Microenvironment and Enhance Cancer Immunotherapy

Host–microbe cross talk in cancer therapy

Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment

Tumor microbiome – an integral part of the tumor microenvironment

The Role of Microbiome in Cancer Cell Stimulation and Therapy

Bacteria and tumor: Understanding the roles of bacteria in tumor genesis and immunology